Log in to save to my catalogue

08 Are DOACs dead? Or do they still have a role in SLE/APS?

08 Are DOACs dead? Or do they still have a role in SLE/APS?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f374f7e13a7347edb6d7c08011544397

08 Are DOACs dead? Or do they still have a role in SLE/APS?

About this item

Full title

08 Are DOACs dead? Or do they still have a role in SLE/APS?

Author / Creator

Publisher

London: Lupus Foundation of America

Journal title

Lupus science & medicine, 2022-04, Vol.9 (Suppl 1), p.A4-A5

Language

English

Formats

Publication information

Publisher

London: Lupus Foundation of America

More information

Scope and Contents

Contents

Since its development in the 1950s, the vitamin K (VKA) antagonist warfarin has been a standard anticoagulant, which for 40 years has utilised the International Normalisation Ratio (INR) to regulate the required dose. Although effective in the treatment of blood clots and reducing the risk of stroke in atrial fibrillation, its use necessitates sign...

Alternative Titles

Full title

08 Are DOACs dead? Or do they still have a role in SLE/APS?

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f374f7e13a7347edb6d7c08011544397

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f374f7e13a7347edb6d7c08011544397

Other Identifiers

E-ISSN

2053-8790

DOI

10.1136/lupus-2022-la.8

How to access this item